KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Goodwill (2019 - 2024)

Historic Goodwill for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q1 2024 value amounting to $47.9 million.

  • Ginkgo Bioworks Holdings' Goodwill fell 1841.81% to $47.9 million in Q1 2024 from the same period last year, while for Mar 2024 it was $47.9 million, marking a year-over-year decrease of 1841.81%. This contributed to the annual value of $49.2 million for FY2023, which is 1822.29% down from last year.
  • Ginkgo Bioworks Holdings' Goodwill amounted to $47.9 million in Q1 2024, which was down 1841.81% from $49.2 million recorded in Q4 2023.
  • Ginkgo Bioworks Holdings' Goodwill's 5-year high stood at $60.2 million during Q4 2022, with a 5-year trough of $1.9 million in Q4 2020.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Goodwill value was $39.4 million (recorded in 2022), while the average stood at $37.8 million.
  • Its Goodwill has fluctuated over the past 5 years, first skyrocketed by 104765.75% in 2021, then plummeted by 1841.81% in 2024.
  • Ginkgo Bioworks Holdings' Goodwill (Quarter) stood at $1.9 million in 2020, then surged by 1047.66% to $21.3 million in 2021, then surged by 182.52% to $60.2 million in 2022, then decreased by 18.22% to $49.2 million in 2023, then fell by 2.7% to $47.9 million in 2024.
  • Its Goodwill stands at $47.9 million for Q1 2024, versus $49.2 million for Q4 2023 and $58.1 million for Q3 2023.